Cuperus Liz J A, Ahmed Wouter, In 't Veen Johannes C C M, Kerstjens Huib A M, Zijp Tanja R, Stevens Jasper, Wessels A Mireille A, Touw Daan J, van Boven Job F M
Pulmonology Department, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Department of Pulmonary Diseases & Tuberculosis, University of Groningen, and University Medical Center Groningen, Groningen, The Netherlands.
Eur J Clin Pharmacol. 2025 Sep 9. doi: 10.1007/s00228-025-03903-w.
Non-adherence to inhaled medication poses a significant clinical and economic burden on patients with respiratory diseases. This narrative review provides an overview of key aspects of hair analysis, in general and specific for inhaled medications, and explores the potential of hair analysis as a novel tool to monitor adherence to inhaled medications.
PubMed searches were conducted to explore four aspects: (1) mechanisms of (inhaled) drug's systemic absorption and deposition in hair; (2) quantification of drugs in hair; (3) factors impacting (inhaled) drug hair concentrations; and (4) clinical studies assessing inhaled medication adherence through hair analysis.
Systemic absorption, deposition, quantification, and interpretation of drug concentrations in hair are complex phenomena and are influenced by various factors. Analysing drug concentrations in hair segments provides insights into adherence variability over up to 3 months. While studies suggest effective incorporation of several inhaled drugs into hair, inter-individual variability is influenced by external (e.g. UV-exposure), drug- (e.g. lipophilicity) and patient-specific (e.g. hair colour) factors, not just by adherence. The impact of these confounding factors on absolute hair concentrations is still unclear. Intra-individual variability unrelated to adherence appears, however, minimal.
Although hair analysis shows promise as a novel objective bioanalytical method for assessing long-term inhaled medication adherence, until further analytical refinement, clinical validation and a clearer understanding of confounding factors, it should not be relied upon as the sole measure of adherence.
吸入药物治疗依从性差给呼吸系统疾病患者带来了重大的临床和经济负担。本叙述性综述概述了毛发分析的关键方面,包括一般情况和吸入药物的具体情况,并探讨了毛发分析作为监测吸入药物治疗依从性的新工具的潜力。
通过PubMed检索来探讨四个方面:(1)(吸入)药物的全身吸收机制及其在毛发中的沉积;(2)毛发中药物的定量分析;(3)影响(吸入)药物毛发浓度的因素;(4)通过毛发分析评估吸入药物治疗依从性的临床研究。
毛发中药物浓度的全身吸收、沉积、定量分析和解读是复杂的现象,受多种因素影响。分析毛发段中的药物浓度可深入了解长达3个月内的依从性变化情况。虽然研究表明几种吸入药物能有效掺入毛发中,但个体间差异不仅受依从性影响,还受外部因素(如紫外线照射)、药物因素(如亲脂性)和患者特异性因素(如头发颜色)影响。这些混杂因素对毛发绝对浓度的影响尚不清楚。然而,与依从性无关的个体内差异似乎最小。
尽管毛发分析有望成为评估长期吸入药物治疗依从性的一种新的客观生物分析方法,但在进一步优化分析方法、进行临床验证并更清楚地了解混杂因素之前,不应将其作为依从性的唯一衡量标准。